Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
PUT
Cisco
CSCO
$438B
| $97.8M | 0.05% |
3,084,800
-889,300
| -22% | -$27.4M |
|
327
CALL
Molson Coors Class B
TAP
$8.01B
| $97.4M | 0.05% |
887,500
+724,200
| +443% | +$73.6M |
|
|
B
328
Barrick Mining
B
$78.3B
| $97.2M | 0.05% |
5,487,564
+29,770
| +0.5% | +$594K |
|
329
CALL
PNC Financial Services
PNC
$97B
| $97M | 0.05% |
1,076,700
+324,800
| +43% | +$27.9M |
|
330
CALL
Agnico Eagle Mines
AEM
$109B
| $96.9M | 0.05% |
1,787,900
+104,200
| +6% | +$5.74M |
|
331
CALL
Expedia Group
EXPE
$38.6B
| $96.6M | 0.05% |
827,400
+26,900
| +3% | +$3.04M |
|
332
CALL
AB InBev
BUD
$155B
| $96.3M | 0.05% |
732,900
-322,200
| -31% | -$40.7M |
|
|
TWX
333
CALL
DELISTED
Time Warner Inc
TWX
| $95.9M | 0.05% |
1,204,600
+187,900
| +18% | +$14.7M |
|
334
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
| $95.3M | 0.05% |
1,091,900
-940,800
| -46% | -$80.9M |
|
335
PUT
Halliburton
HAL
$29.4B
| $94.7M | 0.05% |
2,109,900
-154,200
| -7% | -$6.73M |
|
336
Dell
DELL
$286B
| $94.2M | 0.05% |
+7,019,486
| New | +$95.4M |
|
337
CALL
Williams Companies
WMB
$86.2B
| $93.1M | 0.04% |
3,029,500
+1,302,800
| +75% | +$34.6M |
|
338
PUT
Equinix
EQIX
$105B
| $93M | 0.04% |
258,200
+194,700
| +307% | +$72.2M |
|
339
PUT
Blackrock
BLK
$179B
| $92.5M | 0.04% |
255,200
+73,100
| +40% | +$26.6M |
|
340
CALL
Medtronic
MDT
$119B
| $92.3M | 0.04% |
1,068,200
-526,200
| -33% | -$45.9M |
|
341
Walt Disney
DIS
$186B
| $91.8M | 0.04% |
988,428
+953,880
| +2,761% | +$91.3M |
|
342
PUT
AbbVie
ABBV
$468B
| $91.5M | 0.04% |
1,450,600
-735,500
| -34% | -$47.6M |
|
343
CALL
GSK
GSK
$105B
| $91.3M | 0.04% |
1,694,000
+89,440
| +6% | +$4.9M |
|
344
PUT
Newmont
NEM
$139B
| $91M | 0.04% |
2,314,900
-692,500
| -23% | -$28.7M |
|
|
345
Synchrony
SYF
$25.9B
| $90.9M | 0.04% |
3,247,359
-7,116,733
| -69% | -$195M |
|
|
346
CALL
Blackrock
BLK
$179B
| $90.3M | 0.04% |
249,100
+59,000
| +31% | +$21.5M |
|
347
PUT
Macy's
M
$6B
| $89.4M | 0.04% |
2,412,600
-2,046,500
| -46% | -$74.2M |
|
|
348
CALL
Macy's
M
$6B
| $88.8M | 0.04% |
2,396,400
-429,600
| -15% | -$15.6M |
|
349
CALL
Energy Transfer Partners
ET
$73B
| $88.6M | 0.04% |
5,279,400
-1,631,700
| -24% | -$27.5M |
|
350
CALL
Ulta Beauty
ULTA
$22.4B
| $87.8M | 0.04% |
368,800
+133,000
| +56% | +$33.6M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.